E
Medicenna Therapeutics Corp. MDNAF
$0.8198 -$0.0054-0.65% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -9.50M -8.59M -19.73M -19.68M -19.40M
Total Depreciation and Amortization 47.90K 37.90K 25.40K 13.20K 5.80K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -4.45M -4.20M 8.12M 7.52M 7.27M
Change in Net Operating Assets 1.20M 915.90K -364.80K -222.80K 953.90K
Cash from Operations -12.70M -11.84M -11.95M -12.37M -11.18M
Capital Expenditure -1.50K -24.20K -24.20K -24.20K -22.70K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -1.50K -24.20K -24.20K -24.20K -22.70K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -32.00K -19.00K -- -- --
Issuance of Common Stock 2.97M 23.81M 23.81M 21.90M 20.90M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -300.00K -300.00K -300.00K -300.00K --
Cash from Financing 1.90M 17.14M 17.15M 15.79M 15.27M
Foreign Exchange rate Adjustments -76.00K 633.20K 784.70K -13.40K 197.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -10.88M 5.91M 5.96M 3.38M 4.27M